Bedikian AY - Search Results

1

The role of taxanes in the treatment of metastatic melanoma.

Gogas H, Bafaloukos D, Bedikian AY. Gogas H, et al. Among authors: bedikian ay. Melanoma Res. 2004 Oct;14(5):415-20. doi: 10.1097/00008390-200410000-00013. Melanoma Res. 2004. PMID: 15457099 Review.

2

Phase II evaluation of temozolomide in metastatic choroidal melanoma.

Bedikian AY, Papadopoulos N, Plager C, Eton O, Ring S. Bedikian AY, et al. Melanoma Res. 2003 Jun;13(3):303-6. doi: 10.1097/00008390-200306000-00013. Melanoma Res. 2003. PMID: 12777987 Clinical Trial.

3

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanoma.

Alrwas A, Papadopoulos NE, Cain S, Patel SP, Kim KB, Deburr TL, Bassett R Jr, Hwu WJ, Bedikian AY, Davies MA, Woodman SE, Hwu P. Alrwas A, et al. Among authors: bedikian ay. Melanoma Res. 2014 Aug;24(4):342-8. doi: 10.1097/CMR.0000000000000062. Melanoma Res. 2014. PMID: 24743052 Free PMC article. Clinical Trial.

4

A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma.

McQuade JL, Posada LP, Lecagoonporn S, Cain S, Bassett RL Jr, Patel SP, Hwu WJ, Hwu P, Davies MA, Bedikian AY, Amaria RN. McQuade JL, et al. Among authors: bedikian ay. Melanoma Res. 2016 Dec;26(6):604-608. doi: 10.1097/CMR.0000000000000296. Melanoma Res. 2016. PMID: 27540836 Free PMC article. Clinical Trial.

5

The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanoma.

Yoon C, Papadopoulos NE, Camacho LH, McIntyre S, Alvarado GC, Bedikian AY, Hwu P, Kim KB. Yoon C, et al. Among authors: bedikian ay. Melanoma Res. 2010 Feb;20(1):43-7. doi: 10.1097/CMR.0b013e3283324e2e. Melanoma Res. 2010. PMID: 19952963

6

Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapy.

Hwu WJ, Knight RD, Patnana M, Bassett R, Papadopoulos NE, Kim KB, Hwu P, Bedikian A. Hwu WJ, et al. Melanoma Res. 2010 Dec;20(6):501-6. doi: 10.1097/CMR.0b013e32833faf18. Melanoma Res. 2010. PMID: 20859231 Clinical Trial.

7

Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients.

Homsi J, Bedikian AY, Kim KB, Papadopoulos NE, Hwu WJ, Mahoney SL, Hwu P. Homsi J, et al. Among authors: bedikian ay. Melanoma Res. 2009 Aug;19(4):238-42. doi: 10.1097/CMR.0b013e32832a1e2f. Melanoma Res. 2009. PMID: 19521262 Clinical Trial.

8

Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma.

Homsi J, Bedikian AY, Papadopoulos NE, Kim KB, Hwu WJ, Mahoney SL, Hwu P. Homsi J, et al. Among authors: bedikian ay. Melanoma Res. 2010 Dec;20(6):507-10. doi: 10.1097/CMR.0b013e3283403ce9. Melanoma Res. 2010. PMID: 20881508 Clinical Trial.

9

Phase II evaluation of paclitaxel by short intravenous infusion in metastatic melanoma.

Bedikian AY, Plager C, Papadopoulos N, Eton O, Ellerhorst J, Smith T. Bedikian AY, et al. Melanoma Res. 2004 Feb;14(1):63-6. doi: 10.1097/00008390-200402000-00010. Melanoma Res. 2004. PMID: 15091196 Clinical Trial.

10

Uveal melanoma: natural history and treatment options for metastatic disease.

Wöll E, Bedikian A, Legha SS. Wöll E, et al. Melanoma Res. 1999 Dec;9(6):575-81. Melanoma Res. 1999. PMID: 10661768 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page